Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
HbA1c |
Mean difference in HbA1c at 6 months in the intervention group compared to the control group. Measured with the A1CNow+ point-of-care device in a community location after the completion of the in-home community survey. |
Baseline, 6 months |
|
Secondary |
Physical Activity |
Mean difference in physical activity at 6 months in the intervention group compared to the control group. Measured with the International Physical Activity Questionnaire (International Physical Activity Quotient, IPAQ), included in the community survey. |
Baseline, 6 months |
|
Secondary |
Medication Compliance |
Mean difference in medication compliance at 6 months in the intervention group compared to the control group. Self-reported, via community survey questions. |
Baseline, 6 months |
|
Secondary |
Blood Pressure |
Mean difference in blood pressure at 6 months in the intervention group compared to the control group. Measured using a blood pressure device, the Microlife WatchBP Office Target. |
Baseline, 6 months |
|
Secondary |
Community Residents Newly Diagnosed with Diabetes |
Mean difference in number of community residents newly diagnosed with diabetes at 6 months in the intervention group compared to the control group. Numbers taken from Rural Health Unit databases |
6 months |
|
Secondary |
Hospital admission rates |
Mean difference in hospital admission rates due to diabetes and diabetes-related conditions, hypertension, myocardial infarction, stroke, congestive heart failure at 6 months in the intervention group compared to the control group. Numbers taken from central Department of Health database (12 months before and 12 month after CHAP-P implementation, and divided by mid-year population estimates) |
-12 months, 12 months |
|
Secondary |
Mortality rates |
Mean difference in mortality rates due to diabetes and diabetes-related conditions, hypertension, myocardial infarction, stroke, congestive heart failure based on International Classification of Disease (ICD)-10 codes at 6 months in the intervention group compared to the control group. Numbers taken from Regional Field Health Surveillance Information Systems (measured 12 months before and 12 month after CHAP-P implementation, 6 month estimated by dividing by mid-year population estimates) |
-12 months, 12 months |
|
Secondary |
Quality of Life (EQ5D-5L) |
Mean difference in quality of life at 6 months in the intervention group compared to the control group. Measured with the EuroQol-5 dimension-5 level (EQ5D-5L), included in the community survey |
Baseline, 6 months |
|
Secondary |
Knowledge about Diabetes and Hypertension |
Mean difference in knowledge about diabetes and hypertension at 6 months in the intervention group compared to the control group. Measured with elements of the Health Awareness and Behaviour Tool (HABiT) included in the community survey. |
Baseline, 6 Months |
|
Secondary |
Risk Factors for Diabetes |
Mean difference in risk factors for diabetes at 6 months in the intervention group compared to the control group. Measured with the Finnish Diabetes Risk Score (FINDRISC), included in the community survey |
Baseline, 6 months |
|
Secondary |
Risk Behaviours for Diabetes/Cardiovascular Issues |
Mean difference in risk behavhiours for diabetes/cardiovascular issues (activity, diet, smoking, alcohol, stress) at 6 months in the intervention group compared to the control group. Measured with elements of the Health Awareness and Behaviour Tool (HABiT) included in the community survey. |
Baseline, 6 months |
|
Secondary |
Perceived Concern and Understanding of Risk |
Mean difference in perceived concern and understanding of risk at 6 months in the intervention group compared to the control group. Measured with elements of the Health Awareness and Behaviour Tool (HABiT) included in the community survey. |
Baseline, 6 months |
|
Secondary |
Confidence in Behaviour Change |
Mean difference in confidence in behaviour change at 6 months in the intervention group compared to the control group. Measured with elements of the Health Awareness and Behaviour Tool (HABiT) included in the community survey. |
Baseline, 6 months |
|
Secondary |
Quality-Adjusted Life Years (QALYs) |
Secondary; calculated from the EQ5D-5L. |
12 months |
|
Secondary |
Cost-effectiveness |
Comparing program cost of implementing CHAP-P (collected via team tracking) and healthcare resource utilization costs (collected via self-report from participants during community survey) to percentage reduction in HbA1c and blood pressure. |
12 months |
|
Secondary |
Cost-utility |
Cost of program and healthcare resource utilization costs per QALY |
12 months |
|